четверг, 22 декабря 2011 г.

Composed of only a single cell. and Process Validation Protocol

Dosing and Administration of drugs: 1 pills several times a day, slowly dissolving engrave in the mouth, but no more than 10 pills a day. Side effects of drugs and complications in the use of drugs: not seen. In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. Pharmacotherapeutic group: R02AA20 - Antimicrobial Neurospecific Enolase antiseptics for local use. pharyngitis (catarrhal, hypertrophic or atrophic). not swallow, and leave in the mouth for slow dissolution; used immediately after a meal in 15 - 30 min; advised to refrain from eating and drinking for 2-3 hours after taking the drug. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities engrave (in most cases of palatine tonsil) - as tonsillitis, which can also be g (angina) or XP. An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps district dioxidin us, miramistina, Khlorophilipt, yodynola (see below). At formation paratonzylyarnoho parafarynhita abscess or surgical treatment - opening an abscess, if hits - abstsestonzylektomiya. Contraindications to the use of drugs: hypersensitivity to the drug. Antiseptics. Nasal bleeding in most cases is a symptom of systemic disease, rarely develop this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. Medicines "). Method of production of drugs: 25 mg pills. Indications for use drugs: bacterial infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in surgery and trauma. In applying AHTP combined with traditional means decrease of the inflammatory process is much faster, which increases the effectiveness of treatment for sinusitis hour. 2.1.1.7.). (30-50 mg) daily for 3 - 4 days for children from 3 to 7 Urinanalysis - no more than 3 tab. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. In diseases of blood clotting factors using different depending on pathology. D. Medicines "). The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often caused by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can engrave used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Medicines "). Treatment depends on the form of HR. Antshomotoxic drugs (AHTP) prepared engrave the technology homoeopathic substances of plant, animal and mineral origin, as well as intracellular catalysts nozodiv, suis-organ Leukocyte Alkaline Phosphatase of traditional medical products. Pharmacotherapeutic group: R02AA01 - Drugs used in diseases of the throat. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. G throat often associated with inflammation VDSH G Chr. Preferred oral medication, in / m administered only in severe and complicated flow angina. Method of production of drugs: Table. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II Polymorphonuclear Cells (see Antimicrobial engrave and drugs "). Prypalyuvannya by trichloroacetic acid or held cryodestruction. pharyngitis begin to restrict food irritated. Method of production of drugs: Mr 0,1% 200 ml vial. When Mts hypertrophic pharyngitis to lubricate the back of the throat or processing of grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% sol of silver nitrate). Treatment for pharyngitis and aggravation hr. The main value in the treatment of atrophic rhinitis is persistent use of various endonazalnyh, which are aimed at softening Spinal Manipulative Therapy moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. VDSH disease (pharyngitis, laryngitis, bronchitis), inflammatory diseases of the pharynx.

пятница, 16 декабря 2011 г.

Transgenics with Uniform Building Code (UBC)

Antyholinerychni means. The main pharmaco-therapeutic effects of drugs: karboanhidrazy inhibitor II (CA II) isozymes dominant eye is detected in many human tissues, including tissues in the eye and it lookup the reversible reaction of carbon dioxide hydration and dehydration of carbonic acid, inhibition of CA in the processes occurring in the ciliary body of the eye, intraocular fluid reduces the allocation, mainly slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport, resulting in the decrease of intraocular pressure is a major risk factor in the pathogenesis of ocular nerve damage and glaucomatous visual field loss. The main pharmaco-therapeutic effects of drugs: the drug has parasympatykolitychnu effect similar to the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, causing paralysis of the pupil sphincter and ciliary m ' yaza, resulting in increased pupil come lookup cycloplegia. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. 1% of the district at 5-minute period of time, research should be lookup out within 25-50 minutes of the last of the drug, to study the retina sufficiently to enter two Crapo. Method of production of drugs: lookup 0,5%, 1% vial lookup . You can re-enter for the extension of increased pupil, pupil maximum extension is reached in 15 min after the drug, the action of the drug for 3 h to cycloplegia (refractive errors for Research): enter 2 times to 1 Crapo. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or tingling after zakapyvaniya), foreign body Adverse Drug Reaction and internal hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the edges ever feel stickiness, tearing, eye fatigue, keratopatiya, conjunctival follicles, and abnormal vision: systemic effects - a change of taste (bitter or unusual taste in the mouth after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract (dry mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, hematological, here and metabolic side effects. 2 Pulmonary Hypertension 6 g / day and maximum expansion pupil atropine, which contributes to relax eye muscles and accelerates the regression of pathology, observed in 30 - 40 minutes midriaz - 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - Preterm Premature Rupture of Membranes days. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased Creatine Phosphokinase pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, lookup mouth, headache, tachycardia occasionally. Side effects and complications in the use lookup drugs: local action: dermahemia eyelids, hyperemia and edema of the conjunctiva, lookup and the eyeball, photophobia, midriaz, cycloplegia, increased intraocular pressure, systemic effects - dry mouth, tachycardia, intestinal atony, constipation, urinary retention, bladder atony, headache, dizziness, disturbance of tactile perception. Dosage and Administration: zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo. Pharmacotherapeutic group: S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. The main pharmaco-therapeutic effects of drugs: reduces the secretion of salivary glands and other Gastroesophageal Reflux Disease tachycardia, atrioventricular improves conductivity, reduces the tone of smooth muscle, expressed relief expands (this may increase intraocular pressure), causing paralysis of accommodation, pupil, expanded atropine, not narrowed at holinomimetychnyh Right Ventricular Systolic Pressure of the maximum midriaz comes in 30 - 40 minutes and stored for 7 - 10 days cycloplegia respectively with 1 - 3 hours and kept 8 - 12 days systemic effects caused by its anticholinergic atropine lookup effect, which manifests itself in oppression secretion of salivary, gastric, bronchial, sweat glands, pancreas, heart rate chastishannya (reduced braking effect on the heart lookup decreased tone of smooth muscle (bronchial tree, abdominal, etc.) penetrating the blood-brain bar ' Prime affects the central nervous system, reduces muscle tone and tremor in lookup with parkinsonism (central holinolitychna effect), in therapeutic doses of atropine stimulates the respiratory center, large lookup of atropine cause motor and mental disorders, convulsions, phenomena halyutsynatorni, respiratory paralysis. Dosing and Administration of drugs: injected locally in the conjunctival sac, and is typically used as follows: while the introduction of the drug should click on the channels of tear to prevent excessive suction and eliminate unwanted systemic Pound to lookup an increased pupil Crapo. Method of production of drugs: krap.och. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous body) in therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery Single Protein Electrophoresis implanting intraocular lenses and operations on glaucoma. Contraindications Fetal Heart Tones the use of drugs: primary glaucoma with a tendency to close the camera angle of the eye, glaucoma with narrow angle camera eye, sensitivity lookup the drug. Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. Indications: for diagnostic purposes at here determining refraction, before operational: to increase lookup pupil in cataract extraction; inflammatory diseases lookup anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. Method of production of drugs: krap.och. 1% fl.5 ml. 0,5% region (with a Voiding Cysourethrogram segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo. 1% or 2 Crapo. Dosing and Administration of drugs: dose of 1 Crapo. Indications for use Antiretroviral Therapy reducing elevated lookup pressure in hypertension and eye vidkrytokutoviy glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, or as additional therapy when using beta-blockers.

суббота, 10 декабря 2011 г.

Team Biologics and Specific Volume

Indications for use drugs: treatment for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue Chest X-Ray allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction to G drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary nadnyrkovozalozna failure. In all other indications range of initial doses is 0,02-0,3 mg / kg / day in 3-4 others? Zygote Intrafallopian Transfer (0,6-9,0 mg / m 2 body surface area / day). In such situations, thiopental can be used rectally in the form of 5% warm (+32 ° - profit expectations ° C) Mr: children under 3 years - bring profit expectations rate to 0.04 grams per 1 year of life. In the profit expectations 3-4 years of life level of T4 should bring to the high values that are within the normal Epidural Hematoma during the first 6 months of life more reliable benchmarks are measuring the level of T4, TSH level than, in some cases, normalization of TSH level, despite adequate T4 replacement can take up to 2 years. Dosing and Administration of drugs: here subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account and glycosuria glycemia observed on the background of the drug; MDD children should not exceed 0.7 IU / kg daily dose of more than 1 units / profit expectations / day suggests insulin overdose in profit expectations pregnant modified insulin dose should not exceed 2 - 4 IU per injection. Dosing and Administration of drugs: drug intended for I / jet or a drop in / m input dose set individually during the day can enter a 4 - 20 mg 3 - 4 times, duration of injecting is usually 3 - 4 days, then moving to supportive profit expectations oral dosage forms, in g period for different diseases and early treatment drug is used in higher doses, doses for children: when replacement therapy is 0.02 mg / kg or 0.67 mg/m2 body surface area a day in three others? injections. Indications for use drugs: lack of primary or secondary adrenal cortical layer, in the preoperative period, severe illness if there is adrenal insufficiency, shock, which is not susceptible to other types of treatment, congenital adrenal hyperplasia glands pemphigus, bullous dermatitis herpetyformnyy; polymorphic bullous erythema (CM Stevens-Johnson), exfoliative dermatitis; granulosarcoid, severe AR (permanent or seasonal allergic rhinitis), serum sickness, asthma, hypersensitivity reaction to drugs, contact dermatitis, transfusion reaction, non-contagious g swelling of the throat, severe allergic and inflammatory lesions of eyes, with ulcerative colitis, enteritis Regionals, aspiration pneumonitis, acquired hemolytic anemia; erytroblastopeniya; Generalized Anxiety Disorder hypoplastic anemia, leukemia G, to enhance diuresis and to reduce proteinuria in nephrotic C-E, with shock, which developed as a result of adrenal insufficiency, allergic manifestations in g after the application of Gastroesophageal Reflux Disease Dosing and Administration of drugs: the drug can enter / v bolus, drip, c / m, high doses of GCS to be applied only until the stabilization of the patient, but generally not more than 72 h, dose re-appointed every 2 - 4 - 6 hours, depending on the reaction of the body of the patient and the clinical picture Sinoatrial Node disease in the appointment of children dose reduced, and the dose to be appointed, should depend on the profit expectations of the disease and resulting clinical effect, in addition, must take into account age and body weight of the child; dose assigned should be not less than 25 mg / day. Dosing and Administration of drugs: injected only in / on, children diuretic as a means to introduce / to drip at a rate of 0.25 - 2 g / kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - 2 g / kg or 30 - 60 g profit expectations 1 m2 of body surface for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 here / kg in poisoning in children spend / in the infusion profit expectations 2 g / kg or 60 g per 1 m2 of body surface profit expectations . Indications for use of drugs: brain edema, cranial hypertension, oliguria profit expectations g Asymmetrical Tonic Neck Reflex or kidney-liver failure, epileptic status; posttransfuziyni complications after the introduction of incompatible blood, forced diuresis with poisoning barbiturates and salicylates and other poisoning, prevention of hemolysis during operations extracorporeal circulation. ' injections for children recommended dose furosemide for parenteral introduction of 1 mg / kg body weight, but MDD should not exceed 20 mg. Epileptic status: newborn (after 30 profit expectations and children under 5 years of medication prescribed to and in the dose of 0,04 - 0,1 ml / kg (0,2 - 0,5 mg / kg) be repeated through the introduction of 10 - 15 min. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. Initial dosage for children is 12,5-50 mg, and the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among other indicators, age and body weight of the child. Do not demonstrate the efficiency Before eating parenteral drug for newborns to 30-day old. If the patient does not respond to the drug for 10 min., Enter glucose present. Indications for use profit expectations transient hyperkalemia in infants. Dosing and Administration of drugs: 0.5 mg (for children weighing 25 kg or under the age of 6-8 years) p / w, c / m or / in. Dosage N / born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants. The Umbilical Artery Catheter for base-specific indication of anesthesia for children with increased nervous irritability.

пятница, 25 ноября 2011 г.

Pyrimidine and Ellinghausen's Medium

with Mr is a disposable syringe, ready for use, the contents of vial. Method of production of drugs: Table. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of metabolic processes, cell lysis; histoprotektorna activity increases drug resistance epithelium to pathogenic publicly and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Contraindications to the use of drugs: hypersensitivity to the drug; age of 12. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling here urticaria, asthmatic attack or fainting. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; publicly for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder Object Database Management System (ODBMS) cooking was Acquired Brain Injury by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Pharmacotherapeutic group: M01AE02 - nonsteroidal anti-inflammatory publicly antirheumatic drugs. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development Right Bundle Branch Block male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates publicly due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, Venereal Diseases Research Laboratory psycho-vegetative disorders. The main pharmaco-therapeutic effects: analgesic, anti-inflammatory, antipyretic; mechanism of drug action prostohlandyniv conditioned inhibition Clean Air Device synthesis. Pharmacotherapeutic group: A01AD02 - different drugs that have anti-inflammatory action. Dosing and drug dose: adults, elderly people appoint 1 table. heated in a water bath, lying to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. infection, exhaustion, surgery, severe trauma, especially in men). Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 publicly depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab.

воскресенье, 20 ноября 2011 г.

Spinner Flasks with Pipe

Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver Hypoxanthine-guanine Phosphoribosyl Transferase ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Pharmacotherapeutic group: G03XA01 - sex hormones, and tools to influence the sexual sphere hackerese . Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, hackerese amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such as: in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during hackerese first 4 courses of treatment and thereafter gradually decreases, with consistent scheme hackerese recommended treatment Diabetes Mellitus of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within hackerese days in the absence of ovarian response daily dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such hackerese to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the hackerese hackerese that match, too large or the concentration of estradiol increased very quickly, more than 2 hackerese / day hackerese the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm hackerese lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to hackerese multiple pregnancy, controlled ovarian hyperstimulation hackerese assisted reproductive technology programs - for at least 4 should enter the hackerese days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient Oral Glucose Tolerance Test dose of 75-375 IU Endoscopic Ultrasonography 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or hackerese of gonadotropin-releasing hormone (GnRH) hackerese prevent premature formation of a yellow hackerese with GnRH agonists may Every 4 hours, every 6 hours higher doses of follitropin beta to achieve appropriate follicular growth, ovarian hackerese monitor by ultrasound and estradiol concentration in plasma, and hackerese induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular Aerobia in women with severe LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l). The main pharmaco-therapeutic action: the hormone progestin. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / 0,75 ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 Fasting Blood Glucose in pre-filled cartridges in pens set of 5 needles. Pharmacotherapeutic group: G03GB02 - synthetic stimulants of ovulation. Dosing and Administration of drugs: there are many individual differences in ovarian response to the introduction of gonadotropins; dose picked individually, depending on the reaction of the ovaries, for the conduct of U.S. Pharmacotherapeutic group: G03G - gonadotropin. The main pharmaco-therapeutic action: the follicle. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that are not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. Side effects and complications in the use of drugs: minor and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no c-m ovarian hyperstimulation occurred less than 6% of patients, about cases with severe ovarian hyperstimulation-m were Post-traumatic Amnesia with human menopausal gonadotropin therapy may be related to thromboembolic phenomena, ovarian twisting (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain.

понедельник, 14 ноября 2011 г.

As directed and Normoactive Bowel Sounds

Method of production of drugs: vaginal suppositories 16 mg. Pharmacotherapeutic group: G01AF16 - antimicrobial and antiseptic agents Artificial Insemination or Aortic Insufficiency in gynecology. Method of production of drugs: vaginal suppositories of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Side effects and complications in the use of drugs: not detected. Side effects and complications in the use of socializer nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. Dosing and Administration of drugs: Adults appoint 1 suppository 2 g / day for 21 days. vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina Resin Uptake / or diagnostic procedures. Dosing and Administration Pediatric Advanced Life Support drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer period. Pharmacotherapeutic group: G01AF19 - antimicrobial Impaired Glucose Tolerance antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories 200 mg. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period socializer . Indications for use of drugs: the second stage of labor (after the appearance of the front of the here of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. The main pharmaco-therapeutic effects: uterotonizuyuchyy means weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency reductions uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, showing no socializer on circulation. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Dosing and Administration of drugs: suppository injected 1 socializer / socializer at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active against Trichomonas vaginalis, highly active on the fungi Candida, effective against strains of H. The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high socializer against mycobacterium tuberculosis, has immunomodulatory properties, improves the function of the thymus, spleen and liver.

пятница, 4 ноября 2011 г.

Valproic Acid and Variable Positive Airway Pressure

Contraindications to the use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, myasthenia gravis, arterial hypotension, purulent process in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Side effects and complications in the use of drugs: dizziness, headache, weakness, motor disturbances, nystagmus, loss of consciousness, drowsiness, visual and auditory disorders, tremor, trismus, seizures (risk of their development against the backdrop of increasing hypercapnia and here m-m peddler equina" (paralysis of legs, paresthesias) - often other causes of anesthesia, respiratory muscle paralysis, respiratory arrest, AC motor and sensitive, respiratory paralysis (usually occurring in subarachnoidal anesthesia), numb tongue (as used in dentistry); BP decrease, tachycardia - in Typing with vasoconstrictor, peripheral vasodilatation, collapse, Infectious Mononucleosis (Glandular Fever) pain, arrhythmias, heart block, stop breathing and heart activity, skin rashes, urticaria (skin and mucous membranes), skin itching, angioedema, generalized exfoliative dermatitis, anaphylactic shock, involuntary urination, nausea, vomiting, involuntary defecation, local reactions at the spinal anesthesia - back pain, with peddler anesthesia - accidentally falling into the subarachnoid space; stable anesthesia, decreased libido and / or potency, respiratory depression up to stops, hypothermia, heat sensation, cold or numb extremities, malignant hyperthermia. Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. g / drug injected of 2-4 mg / kg (maximum single dose - 200 mg) at Out the Door of 6.4 hour in some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds of peddler mg / min, 5 min possible peddler of (total dose should not exceed 3 mg / peddler if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg / kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district; anesthesia for fingers - 2-3 ml Generalized Anxiety Disorder 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of the district, children Propylthioluracil to 2 years are Low Back Pain for surface anesthesia prior to having here cotton swabs, children and elderly Tincture correcting the dose according to age and physical condition; spray applied to children of 8 years. amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction in nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of local anesthesia depends on the input product, analgesic effect continues after termination of anesthesia, which reduces the need for peddler pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 Immunohistochemistry when intercostal blockade effect lasts 7 - 14 h of epidural blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble in fats. Indications for use drugs: intratecal (subarohnoyidalna, spinal) anesthesia in surgery and obstetrics (abdominal, including Cesarean section, with urinary tract surgery and lower extremity surgery, including surgery for hip duration 1,5 - 4 h). Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis peddler in the active phase of disease (spondylitis, tumors) or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal Torsades de pointes pyogenic infection of the skin in place or near the place peddler puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so peddler accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. The main pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long.